Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea

scientific article published on 23 January 2017

Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2017PLoSO..1270362A
P356DOI10.1371/JOURNAL.PONE.0170362
P932PMC publication ID5256915
P698PubMed publication ID28114428

P2093author name stringHyo Jun Ahn
Seung Kew Yoon
Jong Young Choi
Jeong Won Jang
Myeong Jun Song
Si Hyun Bae
P2860cites workResponse to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir.Q53664727
Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis BQ82240888
Efficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settingsQ28540372
EASL clinical practice guidelines: Management of chronic hepatitis B virus infectionQ29615868
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort.Q30860824
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.Q30984322
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA levelQ34481474
Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strainsQ34596639
Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patientsQ34948124
Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patientsQ35152367
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patientsQ35231822
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 updateQ35706189
Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral AgentsQ36445048
Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B.Q36757579
Hepatitis B today.Q36830925
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in FranceQ37250436
Hepatitis B virus genotype C prevails among chronic carriers of the virus in KoreaQ37425698
Long-term therapy with nucleoside/nucleotide analogues for chronic hepatitis B in Asian patientsQ38062304
Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.Q39014100
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in GermanyQ40313106
Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection.Q40543517
Three-year efficacy and safety of tenofovir in nucleos(t)ide analog-naïve and nucleos(t)ide analog-experienced chronic hepatitis B patientsQ40835942
Entecavir plus tenofovir combination therapy in patients with multidrug-resistant chronic hepatitis B: results of a multicentre, prospective study.Q40967783
Prediction of virologic response to tenofovir mono-rescue therapy for multidrug resistant chronic hepatitis B.Q41148991
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial.Q41175515
Efficacy and safety of tenofovir in nucleos(t)ide-naïve patients with genotype C chronic hepatitis B in real-life practiceQ41367567
Tenofovir-associated Fanconi syndrome and nephrotic syndrome in a patient with chronic hepatitis B monoinfectionQ41507823
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial.Q41538789
Efficacy of Tenofovir-based Rescue Therapy in Lamivudine-resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination.Q41752080
Tenofovir-based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistanceQ42144275
Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients.Q42251695
Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.Q42678962
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analoguesQ43226767
Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practiceQ43445015
Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxilQ43607727
Predicting cirrhosis risk based on the level of circulating hepatitis B viral loadQ46985831
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjecttenofovirQ155954
chronic hepatitis BQ55779876
chronic hepatitisQ62019625
P304page(s)e0170362
P577publication date2017-01-23
P1433published inPLOS OneQ564954
P1476titleTreatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea
P478volume12

Reverse relations

cites work (P2860)
Q59340545Chronic hepatitis B genotype E in African migrants: response to nucleos(t)ide treatment in real clinical practice
Q59351826Evaluation of drug resistance mutations in patients with chronic hepatitis B
Q58596648Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate

Search more.